Anti-angina drug. This product belongs to the nitrate compound, which has the effect of preventing the free calcium ions in cells, increasing the permeability of cell membranes to potassium ions, dilating coronary blood vessels, continuously increasing coronary blood flow, and inhibiting coronary artery spasm. When dilating coronary blood vessels, it does not affect blood pressure, heart rate, myocardial contractility, and myocardial oxygen consumption. This product also has the effect of inhibiting platelet aggregation and preventing thrombosis.

It participates in amino acid metabolism, synthesis of neurotransmitters, synthesis of collagen and tissue cell interstitial, can reduce the permeability of capillaries, accelerate blood coagulation, stimulate coagulation function, promote iron absorption in the intestine, promote the decrease of blood lipids, increase resistance to infection, participate in detoxification function, and has antihistamine effect and prevents the formation of carcinogens (nitrosamines).

It participates in amino acid metabolism, synthesis of neurotransmitters, synthesis of collagen and tissue cell interstitial, can reduce the permeability of capillaries, accelerate blood coagulation, stimulate coagulation function, promote iron absorption in the intestine, promote the decrease of blood lipids, increase resistance to infection, participate in detoxification function, and has antihistamine effect and prevents the formation of carcinogens (nitrosamines).

It participates in amino acid metabolism, synthesis of neurotransmitters, synthesis of collagen and tissue cell interstitial, can reduce the permeability of capillaries, accelerate blood coagulation, stimulate coagulation function, promote iron absorption in the intestine, promote the decrease of blood lipids, increase resistance to infection, participate in detoxification function, and has antihistamine effect and prevents the formation of carcinogens (nitrosamines).

This product is a hypoglycemic drug. It can reduce fasting and postprandial hyperglycemia in patients with type 2 diabetes, and HbAlc can be reduced by 1% to 2%. The mechanism of lowering blood sugar may be: 1. Increasing the sensitivity of peripheral tissues to insulin and increasing insulin-mediated glucose utilization; 2. Increasing the utilization of glucose by non-insulin-dependent tissues, such as the brain, blood cells, renal medulla, intestines, skin, etc.; 3. Inhibiting hepatic gluconeogenesis and reducing hepatic glucose output; 4. Inhibiting intestinal wall cells from taking up glucose; 6. Inhibiting the biosynthesis and storage of cholesterol and reducing blood triglyceride and total cholesterol levels. Unlike the effect of insulin, this product has no effect of promoting fat synthesis and no obvious hypoglycemic effect on normal people, but has a therapeutic effect on type 2 diabetes.